Pancreatic Cancer Research

ResearcherCapital Medical UniversityNo recent work listed

Yulin Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3563-8998; OpenAlex author ID A5030925445. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

  1. Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network. Co-author DOI 10.21037/tcr-22-709↗
  2. TMEM176A acts as a tumor suppressor gene in pancreatic cancer by inhibiting ERK signaling. Co-author PMID 33593482↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Feng Cao · 2 shared papers, 2020–2022 · strength 0.28
  2. Wentong Mei · 1 shared paper, 2022 · strength 0.16
  3. Yixuan Ding · 1 shared paper, 2022 · strength 0.16
  4. Yuanxu Qu · 1 shared paper, 2022 · strength 0.16
  5. Fei Li · 1 shared paper, 2022 · strength 0.16
  6. Yuchen Jia · 1 shared paper, 2022 · strength 0.16
  7. Ang Li · 1 shared paper, 2020 · strength 0.13
  8. Fei Li · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.